相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural optimization of aminopyrimidine-based CXCR4 antagonists
Fang Zhu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, synthesis, and evaluation of novel CXCR4 antagonists based on an aminoquinoline template
Yu Lin et al.
BIOORGANIC CHEMISTRY (2020)
Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy
Anna E. Vilgelm et al.
FRONTIERS IN IMMUNOLOGY (2019)
Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonists
Zhanhui Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
An update on small molecules targeting CXCR4 as starting points for the development of anti-cancer therapeutics
Fedora Grande et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors
Anneleen van Hout et al.
PLOS ONE (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: Recent advances and future opportunities
Heng Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
CXCR4 signaling in health and disease
Tommaso Pozzobon et al.
IMMUNOLOGY LETTERS (2016)
Molecular Pathways: Targeting the CXCR4-CXCL12 Axis-Untapped Potential in the Tumor Microenvironment
Stefania Scala
CLINICAL CANCER RESEARCH (2015)
Entry inhibitors and their use in the treatment of HIV-1 infection
Aiman A. Haqqani et al.
ANTIVIRAL RESEARCH (2013)
Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists
Valarie M. Truax et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Small Molecule Inhibitors of CXCR4
Bikash Debnath et al.
THERANOSTICS (2013)
Drug Discovery Research Targeting the CXC Chemokine Receptor 4 (CXCR4)
Won-Tak Choi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Methyl Effects on Protein-Ligand Binding
Cheryl S. Leung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The Methylation Effect in Medicinal Chemistry
Eliezer J. Barreiro et al.
CHEMICAL REVIEWS (2011)
Discovery of Novel Small Molecule Orally Bioavailable C-X-C Chemokine Receptor 4 Antagonists That Are Potent Inhibitors of T-Tropic (X4) HIV-1 Replication
Renato T. Skerlj et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
FRESH FROM THE PIPELINE Plerixafor
John F. DiPersio et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Kilogram-Scale Synthesis of the CXCR4 Antagonist GSK812397
Sharon Boggs et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2009)
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects
Nimalie D. Stone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist
WC Liles et al.
TRANSFUSION (2005)
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
WC Liles et al.
BLOOD (2003)
Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry
K Princen et al.
CYTOMETRY PART A (2003)
Human CD34+CXCR4- sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation
O Kollet et al.
BLOOD (2002)
The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2mnull mice
T Lapidot et al.
LEUKEMIA (2002)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
分享论文
